Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development (R&D) of pharmaceutical products.
Financial Results:
Sun Pharma Advanced Research Company Ltd reported Revenues for Q2FY24 of ₹21.00 Crores down from ₹32.00 Crore year on year, a fall of 34.38%.
Total Expenses for Q2FY24 of ₹116.00 Crores up from ₹100.00 Crores year on year, a rise of 16.0%.
Consolidated Net Profit of -₹86.00 Crores from -₹68.00 Crores in the same quarter of the previous year.
The Earnings per Share is -₹2.66, from -₹2.52 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.